Description
Cayman offers vHTS services backed by expertise in medicinal chemistry, structural biology, and Schrödinger suite, a computational platform used to accelerate drug discovery. Our scientists can virtually screen more than 12 million compounds for hit identification, including fragments, drug-like, near drug-like, and lead-like compounds from the Enamine® Stock Screening Compounds Collection and the MilliporeSigma Aldrich Market Select® Screening Collection Phase databases, which are updated quarterly. Glide docking, shape screening, and pharmacophore-based ligand screening are also available in addition to vHTS. We work with you to identify and source top-ranked compounds for further screening.